EMS (pharmaceuticals)
 | |
| Company type | Private |
|---|---|
| Industry | Pharmaceuticals and health care |
| Founded | 1950 |
| Headquarters | São Bernardo do Campo and Hortolândia, Brazil |
Key people | Waldir Eschberger, (CEO) |
| Products | Drugs and generic drug |
| Revenue |  US$ 2.8 billion (2012) |
Number of employees | 4,500 |
| Website | www.ems.com.br |
EMS is the biggest domestic pharmaceutical company in Brazil,.[1] Founded in the mid-1950s, the company has two industrial plants based in São Bernardo do Campo and Hortolândia, in the state of São Paulo.
EMS operates through five divisions:
- EMS Similars - markets similares; a class of pharmaceuticals peculiar to the Brazilian market. Not generics but not original brands either;
- EMS Generics - markets generics;
- EMS Sigma Pharma - markets branded medicines;
- EMS Hospital - markets drugs to hospitals;
- EMS Consumer - markets OTC drugs.
Today the company has a presence in over 30 countries through joint-ventures and strategic partnerships with other pharmaceutical companies.
EMS's Brazilian main competitors are Hypermarcas, Eurofarma, Aché and Cristália.
References
- ^ Focus Reports "Brazil: Big Dancer Takes the Floor" Pharmaceutical Executive, October 2007
External links
 | This Brazilian corporation or company article is a stub. You can help Wikipedia by expanding it. |